Literature DB >> 22613963

Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats.

Lie Wang1, Xiao-Huang Tu, Peng Zhao, Jing-Xiang Song, Zhong-Dong Zou.   

Abstract

Severe acute pancreatitis (SAP) is initiated by the premature activation of digestive enzymes within the pancreatic acinar cells, leading to self-digestion and inflammatory responses in pancreatic ductal cells, thus giving rise to systemic inflammatory response syndrome (SIRS). The most common and serious SIRS is pancreatitis-associated lung injury, and inflammatory mediators play an important role in its pathogenesis. Bone marrow-derived mesenchymal stem cells (MSCs) are differentiated into alveolar endothelial cells to replace the damaged alveolar endothelial cells and inhibit inflammatory response in the injured lung tissues. In this study, we aimed to investigate the therapeutic effect of bone marrow-derived MSCs in rats with pancreatitis-associated lung injury. Experimental SAP was induced by a retrograde injection of 5% sodium taurocholate into the biliopancreatic duct of 75 male Sprague-Dawley rats, which were divided into the SAP group (n=25), the MSC group (n=25) and the sham-operated group (n=25) to explore the pathology and function of lung tissues and the regulation of inflammatory mediators. Pulmonary edema was estimated by measuring water content in the lung tissues. Pulmonary myeloperoxidase (MPO) activity was detected using spectrophotometry. Serum amylase was detected using the Automatic Biochemistry Analyzer. Tumor necrosis factor-α (TNF-α) and substance P (SP) mRNA levels were determined by quantitative reverse transcriptase-polymerase chain reaction. Our results showed that serum amylase activity was significantly decreased in the MSC group compared to the SAP group. Pulmonary edema was significantly diminished (p<0.05) in the MSC group compared to the SAP group. Typical acute lung injury was observed in the SAP group, and the pathological changes were mild in the MSC group. The expression of TNF-α and SP mRNA in lung tissue was diminished in the MSC group compared to the SAP group. In conclusion, MSC transplantation attenuates pulmonary edema and inflammation, and reduces the mRNA expression of TNF-α and SP in pancreatitis-associated lung injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613963     DOI: 10.3892/mmr.2012.922

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  Stem cell therapy: a potential for the perils of pancreatitis.

Authors:  Harleen Chela; Bhupinder S Romana; Markandeya Madabattula; Abdulmajeed A Albarrak; Mohamad H Yousef; Sami Samiullah; Veysel Tahan
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

3.  Role of bone marrow mesenchymal stem cells in L-arg-induced acute pancreatitis: effects and possible mechanisms.

Authors:  Guojian Yin; Guoyong Hu; Rong Wan; Ge Yu; Xiaofeng Cang; Jianbo Ni; Jie Xiong; Yanling Hu; Miao Xing; Yuting Fan; Wenqin Xiao; Lei Qiu; Shaofeng Wang; Xingpeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs.

Authors:  Darwin J Prockop; Joo Youn Oh; Ryang Hwa Lee
Journal:  Mol Ther       Date:  2017-06-22       Impact factor: 11.454

5.  Bone marrow mesenchymal stem cells protect lungs from smoke inhalation injury by differentiating into alveolar epithelial cells via Notch signaling.

Authors:  Yuan Liang; Cunping Yin; X I Lu; Hua Jiang; Faguang Jin
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

6.  Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats.

Authors:  Hang Zhao; Zhiying He; Dandan Huang; Jun Gao; Yanfang Gong; Hongyu Wu; Aifang Xu; Xiangjun Meng; Zhaoshen Li
Journal:  Stem Cells Int       Date:  2016-09-18       Impact factor: 5.443

Review 7.  Current status of diagnosis and Mesenchymal stem cells therapy for acute pancreatitis.

Authors:  Fahad Munir; Muhammad B Jamshed; Numan Shahid; Syed A Muhammad; Noor B Ghanem; Zhang Qiyu
Journal:  Physiol Rep       Date:  2019-11

Review 8.  Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19.

Authors:  Loubna Mazini; Mohamed Ezzoubi; Gabriel Malka
Journal:  Stem Cell Res Ther       Date:  2021-01-04       Impact factor: 6.832

9.  Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.

Authors:  Manoj M Lalu; David Moher; John Marshall; Dean Fergusson; Shirley Hj Mei; Malcolm Macleod; Gilly Griffin; Alexis F Turgeon; Michael Rudnicki; Jason Fishman; Marc T Avey; Becky Skidmore; Jeremy M Grimshaw; Duncan J Stewart; Kavita Singh; Lauralyn McIntyre
Journal:  Syst Rev       Date:  2014-05-23

Review 10.  Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.

Authors:  Lauralyn A McIntyre; David Moher; Dean A Fergusson; Katrina J Sullivan; Shirley H J Mei; Manoj Lalu; John Marshall; Malcolm Mcleod; Gilly Griffin; Jeremy Grimshaw; Alexis Turgeon; Marc T Avey; Michael A Rudnicki; Mazen Jazi; Jason Fishman; Duncan J Stewart
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.